Table 4.
Variables | OSDI Score 2–3 Weeks After IPL+LLL | OSDI Score 6 Months After IPL+LLL | ||
---|---|---|---|---|
R | P value | R | P value | |
Severity of dry eye by OSDI 12* | 0.603 | <0.001 | 0.346 | 0.008 |
Severity of dry eye by ME-CHECK®* | 0.533 | <0.001 | 0.472 | <0.001 |
Corneal fluorescein stainingꭞ | 0.487 | <0.001 | 0.220 | 0.096 |
Previous ocular surgery | 0.424 | 0.001 | 0.302 | 0.021 |
Female gender | 0.388 | 0.002 | 0.202 | 0.129 |
Lowering ocular hypertension drops | 0.277 | 0.030 | −0.082 | 0.541 |
Previous cataract surgery | 0.271 | 0.033 | 0.198 | 0.136 |
Schirmer testꭞ | −0.245 | 0.055 | −0.197 | 0.138 |
Blink rateꭞ | −0.216 | 0.091 | −0.154 | 0.247 |
Lipid layer thicknessꭞ | 0.214 | 0.094 | −0.042 | 0.756 |
Degree of skin pigmentation | −0.212 | 0.097 | 0.142 | 0.287 |
Tear meniscus heightꭞ | −0.152 | 0.238 | −0.125 | 0.351 |
Non-invasive break up timeꭞ | 0.137 | 0.292 | 0.121 | 0.366 |
Area loss of the MGꭞ | 0.102 | 0.429 | 0.037 | 0.785 |
Age | 0.075 | 0.564 | −0.126 | 0.345 |
Tear osmolarityꭞ | −0.070 | 0.587 | −0.005 | 0.968 |
Notes: *Before treatment. ꭞAfter treatment. Bold text represents a statistically significant p-value.
Abbreviations: OSDI, ocular surface disease index; IPL, intense pulsed light therapy; LLL, low level light therapy; MG, meibomian glands.